Janacti

sitagliptin and pioglitazone · Merck Sharp & Dohme (Europe), Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Janacti, covering 2011-11-14 to 2011-11-22. Get the full timeline:

Most recent: EMA Application withdrawn: Janacti — Merck Sharp Dohme Ltd.